Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

There were several interesting developments this week on the federal level.  We’ll start off with the news that the Senate may not take up the issue of banking in the marijuana industry.  Sen. Mike Crapo (R.

Cannabidiol (CBD) competed with Vitamin C as a top ingredient in new cosmetic products this past year, with promises of having anti-inflammatory effects and other healing properties. Amid the hype, at the end of 2018, the Agriculture Improvement Act of 2018, P.L. 115-334 (the “2018 Farm Bill”) was signed into law, changing the marketing of hemp and derivatives of cannabis and further removing hemp from the Controlled Substances Act thereby making it no longer an illegal substance under federal law. See Section 297A. The 2018 Farm Bill amended the definition of “hemp” to specifically include “all derivatives, extracts, cannabinoids,” which has been construed as an attempt to include hemp-based CBD under the definition of industrial hemp. The 2018 Farm Bill allows, subject to certain restrictions, hemp cultivation, along with the sale, transport (including via interstate commerce), and possession of hemp-derived products.
Continue Reading

Welcome back to The Week in Weed, your Friday look at what’s happening in the world of legalized marijuana.

The big news this week, at least on the federal level, is that hemp legalization appears to be coming sooner rather than later.  Nothing like having an important Senator on your side to smooth the